UBS Group
MACAU

UBS Group’s Moringa Acquisition Corp Units MACAU Stock Holding History

UBS Group’s Portfolio MACAU Stock Details MACAU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-50
Closed -$479 – 10165
2023
Q3 		$479 Buy
+50
New +$532 ﹤0.01% 8467
2023
Q1 		– Sell
-1,523
Closed -$15.7K – 10736
2022
Q4 		$15.7K Buy
1,523
+300
+25% +$3K ﹤0.01% 7958
2022
Q3 		$12K Sell
1,223
-290
-19% -$2.87K ﹤0.01% 8205
2022
Q2 		$15K Buy
1,513
+200
+15% +$1.97K ﹤0.01% 7327
2022
Q1 		$13K Sell
1,313
-460
-26% -$4.55K ﹤0.01% 8092
2021
Q4 		$18K Buy
1,773
+49
+3% +$489 ﹤0.01% 8001
2021
Q3 		$17K Sell
1,724
-853
-33% -$8.51K ﹤0.01% 7361
2021
Q2 		$26K Buy
2,577
+215
+9% +$2.15K ﹤0.01% 7090
2021
Q1 		$23K Buy
+2,362
New +$24.1K ﹤0.01% 7251

Other funds holding MACAU

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group's MACAU Position: Q4 2023 in Review

UBS Group sold out of Moringa Acquisition Corp Units (MACAU) in Q4 2023, closing a stake of 50 shares — an estimated $479 sold.

UBS Group first reported a position in MACAU in Q1 2021 and held it in 9 quarters. The position peaked at $26K in Q2 2021. 1 fund tracked by Wall St. Rank holds MACAU as of Q4 2023.

  • UBS Group reported no remaining Moringa Acquisition Corp Units position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 50 Moringa Acquisition Corp Units shares in Q4 2023, an estimated $479.
  • UBS Group first reported a position in Moringa Acquisition Corp Units in Q1 2021 and held it in 9 quarters.
  • UBS Group's Moringa Acquisition Corp Units position peaked at $26K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Moringa Acquisition Corp Units as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.